BG Medicine(美國)

BG Medicine

美國BGMedicine,Inc.www.bg-medicine.comBGMedicine是一家致力于發現、開發和商品化以生物標志物為基礎的新型分子診斷技術，并借此來改善患者治療結果和控制醫療費用的生命科學公司。該公司宣布，在D輪融資中獲得總額為4000萬美元的資金。此輪融資包括新投資者LeggMasonCapitalManagement、GEAssetManagement、SMALLCAPWo rldFund和現有投資者FlagshipVentures、GildeHealthcarePartners、Humana、SteliosPapadopoulos。該筆資金將用于推動公司現有的兩個診斷產品的研發和商業化，并將支持公司繼續進行其他產品的研發。BGMedicineisalifesciencescompanyfocusedonthediscovery,developmentandcommercializationofnovelmoleculardiagnosticsbasedonbiomarkerstoimprovepatientoutcomesandcontainhealthcarecosts.Ourtechnologyplatformuniquelypositionsustorapidlyandcost-effectivelydiscovernewhigh-valuebiomarkersoverabroadrangeoftherapeuticcategoriesthatpromisetobehighlycorrelatedtoclinicaloutcomes.Wehavebuiltabroadproductpipelinethatfocusesoncardiovasculardisease,cancerandCNSdisordersthroughacademiccollaborationsandinitiativeswithmajorpharmaceuticalcomp